Pressure BioSciences, Inc. Reports Q1 2022 Financial Results

3 years ago

Focused on the Successful Launch of its "Early Access Program" for the UST Platform, Company Already Negotiating with Four Potential…

CHU Toulouse in France Starts Liver and Lung Perfusion Programs Using XVIVO Technologies

3 years ago

GOTHENBURG, SWEDEN / ACCESSWIRE / May 19, 2022 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV)The CHU Toulouse hospital in France…

Altamira Therapeutics to Present at the 2022 H.C. Wainwright Global Investment Conference

3 years ago

HAMILTON, BERMUDA / ACCESSWIRE / May 19, 2022 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing therapeutics that…

Occlutech Signs Exclusive US Distribution Agreement with B. Braun Interventional Systems Inc., an Affiliate of B. Braun Medical Inc.

3 years ago

SCHAFFHAUSEN, CH / ACCESSWIRE / May 19, 2022 / Occlutech Holding AGOcclutech Holding AG (Occlutech), a leading specialist provider of…

Bonum Health(TM) (TRxADE HEALTH Company) Launches Veterinary Telemedicine Services

3 years ago

TAMPA, FL / ACCESSWIRE / May 19, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) an integrated drug procurement, delivery, and healthcare…

TransCode Therapeutics Acquires Option for Radiotheranostic Technology

3 years ago

BOSTON, May 19, 2022 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to defeating cancer…

U.K. Member of Parliament Crispin Blunt To Inaugurate Psilocybin Cultivation Facility At Optimi Health Grand Opening

3 years ago

Blunt to speak on the importance of understanding psilocybin’s potential role in mental health, reducing barriers to continued research in…

Biora Therapeutics Announces New Patents for Targeted Therapeutics Platform

3 years ago

Marks 29 Patents Worldwide Directed to Biora’s Device Localization TechnologySAN DIEGO, May 19, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc.…

NeuroMetrix Reports that Quell® Wearable Neuromodulation Device has Received FDA De Novo Authorization as First Non-Pharmacological Treatment for Fibromyalgia

3 years ago

WOBURN, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced U.S. Food and Drug Administration (FDA)…

National Research Corporation Announces Appointment to Board of Directors

3 years ago

Microsoft Executive Parul Bhandari Brings Digital Transformation Expertise to BoardLINCOLN, Neb., May 19, 2022 (GLOBE NEWSWIRE) -- National Research Corporation,…